Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedApr 3, 2024HYDROmorphone HCl 20 mg/100mL in 0.9% Sodium Chloride InjectionLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0404-2024Class IITerminatedApr 3, 2024fentaNYL 2Lack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0403-2024Class IITerminatedApr 3, 2024fentaNYL 1Lack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0402-2024Class IITerminatedApr 3, 2024fentaNYL 500 mcg/100 mLLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0401-2024Class IITerminatedApr 3, 2024fentaNYL 500 mcg/100 mLLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0400-2024Class IITerminatedApr 3, 2024fentaNYL 100 mcg/50 mLLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0399-2024Class IITerminatedApr 3, 2024fentaNYL 200 mcg/100 mLLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0398-2024Class IITerminatedApr 3, 2024fentaNYL 200 mcg/100 mLLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0397-2024Class IITerminatedApr 3, 2024fentaNYL 2Lack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0396-2024Class IITerminatedApr 3, 2024fentaNYL 2Lack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0395-2024Class IITerminatedApr 3, 2024Diltiazem HCl 125 mg in 0.9% Sodium Chloride InjectionLack of Assurance of SterilitySCA Pharmaceuticals, LLC · D-0394-2024Class ITerminatedMar 27, 2024Neptune's FixMarketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.Super Chill Products · D-0393-2024Class IIOngoingMar 27, 2024InfumorphThe filter included in the carton has an expiration date that has expired prior to the expiration date of the actual product lot.Hikma Pharmaceuticals USA Inc. · D-0392-2024Class IIOngoingMar 27, 2024Nicardipine Hydrochloride InjectionFailed Impurities/Degradation Specifications: Out of specification for organic impuritiesEugia US LLC · D-0391-2024Class IIOngoingMar 27, 2024Nicardipine Hydrochloride InjectionFailed Impurities/Degradation Specifications: Out of specification for organic impuritiesEugia US LLC · D-0390-2024Class IIITerminatedMar 27, 2024Digoxin TabletsCross Contamination with Other Products:(mycophenolate mofetil).Novitium Pharma LLC · D-0389-2024Class IITerminatedMar 20, 2024Telmisartan TabletsFailed Stability Specifications: Out of specification for blend uniformity.Micro Labs Limited · D-0388-2024Class IIOngoingMar 20, 2024Broncochem Cold & TeaStability testing failures for one or two of the four active pharmaceutical ingredients among the finished drug products, i.e., Phenylephrine HCL, and/or...Global Corporation · D-0387-2024Class IIOngoingMar 20, 2024Broncochem Cold & Flu Syrup KidsStability testing failures for one or two of the four active pharmaceutical ingredients among the finished drug products, i.e., Phenylephrine HCL, and/or...Global Corporation · D-0386-2024Class IITerminatedMar 20, 2024Tobramycin for InjectionFailed Stability Specification: Water determination was found not complying with specification.Eugia US LLC · D-0385-2024Class IIOngoingMar 20, 2024hyalogic For Dry EyesLack of Assurance of SterilityOptikem International, Inc. · D-0384-2024Class IIOngoingMar 20, 2024TRP Natural Eyes Red Eye ReliefLack of Assurance of SterilityOptikem International, Inc. · D-0383-2024Class IIOngoingMar 20, 2024TRP Natural Eyes Pink Eye ReliefLack of Assurance of SterilityOptikem International, Inc. · D-0382-2024Class IIOngoingMar 20, 2024TRP Natural Eyes Aging Eye ReliefLack of Assurance of SterilityOptikem International, Inc. · D-0381-2024Class IIOngoingMar 20, 2024TRP Natural Eyes Floaters ReliefLack of Assurance of SterilityOptikem International, Inc. · D-0380-2024Class IIOngoingMar 20, 2024TRP Eye strain ReliefLack of Assurance of SterilityOptikem International, Inc. · D-0379-2024Class IIOngoingMar 20, 2024TRP Natural Eyes Dryness ReliefLack of Assurance of SterilityOptikem International, Inc. · D-0378-2024Class IIOngoingMar 20, 2024TRP Eye Twitching ReliefLack of Assurance of SterilityOptikem International, Inc. · D-0377-2024Class IIOngoingMar 20, 2024TRP Blur ReliefLack of Assurance of SterilityOptikem International, Inc. · D-0376-2024Class IIOngoingMar 20, 2024TRP Natural Eyes Allergy Eyes ReliefLack of Assurance of SterilityOptikem International, Inc. · D-0375-2024Class IITerminatedMar 20, 2024BetimolLack of Assurance of Sterility: Out of specification for volume and compromised container closure.Thea Pharma, Inc. · D-0374-2024Class IITerminatedMar 20, 2024Bicillin L-AcGMP Deviations: Products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-0373-2024Class IITerminatedMar 20, 2024Infuvite Adult Multiple vitamins injectioncGMP Deviations: Products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-0372-2024Class IITerminatedMar 20, 2024Rocuronium Bromide InjectioncGMP Deviations: Products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-0371-2024Class IITerminatedMar 20, 2024Potassium Chloride for Injection Concentrate USPLack of assurance of sterility: pinholes, within the blue label characters on the EXCEL bag, specifically within the dotted characters on the label, resulting in leaks.B. Braun Medical Inc · D-0370-2024Class IIOngoingMar 20, 2024Febuxostat Tablets 80mgCGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.Sun Pharmaceutical Industries Inc · D-0369-2024Class IIOngoingMar 20, 2024Febuxostat Tablets 40mgCGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.Sun Pharmaceutical Industries Inc · D-0368-2024Class IIITerminatedMar 13, 2024Mercaptopurine TabletsFailed Dissolution Specifications: results slightly under spec at at 9-months.Stason Pharmaceuticals, Inc. · D-0367-2024Class IIOngoingMar 13, 2024Methylprednisolone acetate Injectable SuspensionFailed Dissolution SpecificationsEugia US LLC · D-0366-2024Class IIIOngoingMar 13, 2024Clindamycin Phosphate Topical Solution USPDefective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.Contract Pharmaceuticals Limited Canada · D-0365-2024